EUROPEAN COMMISSION GRANTS ORPHAN DESIGNATION FOR LUNDBECK'S INVESTIGATIONAL ANTI-ACTH MONOCLONAL ANTIBODY ASEDEBART FOR CUSHING'S SYNDROME OF ENDOGENOUS ORIGIN

Reuters · 3d ago

Please log in to view news